Form 8-K - Current report:
SEC Accession No. 0001437749-25-006457
Filing Date
2025-03-06
Accepted
2025-03-06 16:08:27
Documents
16
Period of Report
2025-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20250214_8k.htm   iXBRL 8-K 27395
2 EXHIBIT 99.1 ex_778773.htm EX-99.1 107323
7 logo.jpg GRAPHIC 8156
  Complete submission text file 0001437749-25-006457.txt   293673

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20250306.xsd EX-101.SCH 3440
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20250306_def.xml EX-101.DEF 11815
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20250306_lab.xml EX-101.LAB 15847
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20250306_pre.xml EX-101.PRE 12030
18 EXTRACTED XBRL INSTANCE DOCUMENT cont20250214_8k_htm.xml XML 2966
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 25715254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)